LONALeonaBio, Inc.

$26M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$479,000

Operating Income

-$64M

Net Income

-$55M

EPS (Diluted)

$-14.90

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$45M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$332M

Total Liabilities

$11M

Stockholders' Equity

$321M

Cash & Equivalents

$111M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$479,000	-$2M	+76.0%
Operating Income	-$64M	-$20M	-220.2%
Net Income	-$55M	-$20M	-174.9%

LONA FY 2021 Earnings — LeonaBio, Inc. Revenue & Financial Results | Market Cap Arena